Nasdaq Biotechnology Ishares (IBB) 257.25 $IBB
'Fast Money' Recap: A Game-Changing Twitter Quarter
at The Street - Wed Jul 30, 4:00AM CDT
The trading panel looked at the social media company's earnings, Panera Bread and Spirit Airlines.
Look for Shares of iShares Nasdaq Biotechnology Index to Potentially Pullback after Yesterday's 1.12% Rise
Comtex SmarTrend(R) - Tue Jul 22, 4:11PM CDT
iShares Nasdaq Biotechnology Index (AMEX:IBB) traded in a range yesterday that spanned from a low of $252.27 to a high of $254.88. Yesterday, the shares gained 1.1%, which took the trading range above the 3-day high of $251.52 on volume of 1.1 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
Are Biotechs Overvalued?
Alex Dumortier, CFA, The Motley Fool - Motley Fool - Mon Jul 21, 9:23AM CDT
U.S stocks are marginally lower on Monday morning, with the benchmark S&P 500 and the narrower Dow Jones Industrial Average down 0.38% and 0.48%, respectively, at 10:18 a.m. EDT. This week is relatively light in terms of economics data, but...
The Fed's Valuation Concerns Put These Growth ETFs in Focus - ETF News And Commentary
Zacks Equity Research - ZACKS - Thu Jul 17, 9:00AM CDT
Thanks to Yellen and her comments, these high growth ETFs could be in focus.
iShares Nasdaq Biotechnology Index Set to Possibly Rebound After Yesterday's Selloff of 1.43%
Comtex SmarTrend(R) - Wed Jul 16, 4:30PM CDT
iShares Nasdaq Biotechnology Index (AMEX:IBB) traded in a range yesterday that spanned from a low of $248.20 to a high of $253.42. Yesterday, the shares fell 1.4%, which took the trading range below the 3-day low of $250.89 on volume of 2.4 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
Yellen, Icahn Comments Put a Lid on Small-Cap Stocks, May Hurt Larger Market
at The Street - Wed Jul 16, 10:40AM CDT
Recent comments by Fed Chair Janet Yellen and activist investor Carl Icahn have led to selling pressure in small-cap stocks.
Stock Market Today: Social Media, Biotech Suffer as Janet Yellen Shares Concerns on Valuation
at The Street - Tue Jul 15, 3:19PM CDT
Major indices trembled and the Nasdaq slid Tuesday following Fed Chair Janet Yellen's remarks on biotech and social media valuations.
Fed: These Two Industries Look Overvalued - Real Time Insight
Todd Bunton - Zacks Investment Research - Tue Jul 15, 1:29PM CDT
In a recent report to Congress, the Fed highlighted "stretched" valuations in two specific industries.
Fed Chair Yellen Says Small Biotech Stocks Over-Valued
at The Street - Tue Jul 15, 12:10PM CDT
Biotech indices plunge on cautious remarks made by Fed Chairwoman during Congressional testimony.
Stock Market Today: Biotech, Social Media Stocks Slide Following Yellen's Remarks
at The Street - Tue Jul 15, 11:14AM CDT
Major U.S. stock markets slide Tuesday following Fed Chair Janet Yellen's remarks on biotech and social media valuations.
Earnings Preview: Abbott Laboratories and Johnson & Johnson
George Budwell, The Motley Fool - Motley Fool - Mon Jul 14, 1:30PM CDT
The health care sector in general, and biotech industry in particular, have now shrugged off their earlier first quarter dip. For instance, the iShares Nasdaq Biotech Index has rallied a little over 13% year to date, although this closely watched...
'Fast Money' Recap: Confusion in the Market
at The Street - Fri Jul 11, 4:00AM CDT
The trading panel discussed whether investors are too complacent and whether it's a good idea to buy Microsoft again.
'Fast Money' Recap: Digging Into Oil Prices
at The Street - Thu Jul 10, 4:00AM CDT
The trading panel looked at whether WTI will go lower, how that will affect transportation stocks and how successful a Kim Kardashian mobile game app can be.
iShares Nasdaq Biotechnology Index Falls 2.14% on Heavy Volume: Watch For Potential Rebound
Comtex SmarTrend(R) - Tue Jul 08, 4:32PM CDT
iShares Nasdaq Biotechnology Index (AMEX:IBB) traded in a range yesterday that spanned from a low of $251.76 to a high of $258.50. Yesterday, the shares fell 2.1%, which took the trading range below the 3-day low of $258.83 on volume of 2.2 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
SmarTrend Watching for Potential Rebound in Shares of iShares Nasdaq Biotechnology Index After 2.14% Loss
Comtex SmarTrend(R) - Tue Jul 08, 4:31PM CDT
iShares Nasdaq Biotechnology Index (AMEX:IBB) traded in a range yesterday that spanned from a low of $251.76 to a high of $258.50. Yesterday, the shares fell 2.1%, which took the trading range below the 3-day low of $258.83 on volume of 2.2 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
Today's 3 Most Volatile Biotech Stocks
Todd Campbell, The Motley Fool - Motley Fool - Tue Jul 08, 4:05PM CDT
Biotechnology stocks are never short on volatility and today was no different as markets turned lower and biotech stocks were particularly hard hit. The Nasdaq Biotechnology Index ETF dropped more than 2% as investors embraced safety and avoided...
'Fast Money' Recap: A Game-Changing Twitter Quarter
at The Street - Wed Jul 30, 4:00AM CDT
The trading panel looked at the social media company's earnings, Panera Bread and Spirit Airlines.
Look for Shares of iShares Nasdaq Biotechnology Index to Potentially Pullback after Yesterday's 1.12% Rise
Comtex SmarTrend(R) - Tue Jul 22, 4:11PM CDT
iShares Nasdaq Biotechnology Index (AMEX:IBB) traded in a range yesterday that spanned from a low of $252.27 to a high of $254.88. Yesterday, the shares gained 1.1%, which took the trading range above the 3-day high of $251.52 on volume of 1.1 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
Are Biotechs Overvalued?
Alex Dumortier, CFA, The Motley Fool - Motley Fool - Mon Jul 21, 9:23AM CDT
U.S stocks are marginally lower on Monday morning, with the benchmark S&P 500 and the narrower Dow Jones Industrial Average down 0.38% and 0.48%, respectively, at 10:18 a.m. EDT. This week is relatively light in terms of economics data, but...
The Fed's Valuation Concerns Put These Growth ETFs in Focus - ETF News And Commentary
Zacks Equity Research - ZACKS - Thu Jul 17, 9:00AM CDT
Thanks to Yellen and her comments, these high growth ETFs could be in focus.
iShares Nasdaq Biotechnology Index Set to Possibly Rebound After Yesterday's Selloff of 1.43%
Comtex SmarTrend(R) - Wed Jul 16, 4:30PM CDT
iShares Nasdaq Biotechnology Index (AMEX:IBB) traded in a range yesterday that spanned from a low of $248.20 to a high of $253.42. Yesterday, the shares fell 1.4%, which took the trading range below the 3-day low of $250.89 on volume of 2.4 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
Yellen, Icahn Comments Put a Lid on Small-Cap Stocks, May Hurt Larger Market
at The Street - Wed Jul 16, 10:40AM CDT
Recent comments by Fed Chair Janet Yellen and activist investor Carl Icahn have led to selling pressure in small-cap stocks.
Stock Market Today: Social Media, Biotech Suffer as Janet Yellen Shares Concerns on Valuation
at The Street - Tue Jul 15, 3:19PM CDT
Major indices trembled and the Nasdaq slid Tuesday following Fed Chair Janet Yellen's remarks on biotech and social media valuations.
Fed: These Two Industries Look Overvalued - Real Time Insight
Todd Bunton - Zacks Investment Research - Tue Jul 15, 1:29PM CDT
In a recent report to Congress, the Fed highlighted "stretched" valuations in two specific industries.
Fed Chair Yellen Says Small Biotech Stocks Over-Valued
at The Street - Tue Jul 15, 12:10PM CDT
Biotech indices plunge on cautious remarks made by Fed Chairwoman during Congressional testimony.
Stock Market Today: Biotech, Social Media Stocks Slide Following Yellen's Remarks
at The Street - Tue Jul 15, 11:14AM CDT
Major U.S. stock markets slide Tuesday following Fed Chair Janet Yellen's remarks on biotech and social media valuations.
Earnings Preview: Abbott Laboratories and Johnson & Johnson
George Budwell, The Motley Fool - Motley Fool - Mon Jul 14, 1:30PM CDT
The health care sector in general, and biotech industry in particular, have now shrugged off their earlier first quarter dip. For instance, the iShares Nasdaq Biotech Index has rallied a little over 13% year to date, although this closely watched...
'Fast Money' Recap: Confusion in the Market
at The Street - Fri Jul 11, 4:00AM CDT
The trading panel discussed whether investors are too complacent and whether it's a good idea to buy Microsoft again.
'Fast Money' Recap: Digging Into Oil Prices
at The Street - Thu Jul 10, 4:00AM CDT
The trading panel looked at whether WTI will go lower, how that will affect transportation stocks and how successful a Kim Kardashian mobile game app can be.
iShares Nasdaq Biotechnology Index Falls 2.14% on Heavy Volume: Watch For Potential Rebound
Comtex SmarTrend(R) - Tue Jul 08, 4:32PM CDT
iShares Nasdaq Biotechnology Index (AMEX:IBB) traded in a range yesterday that spanned from a low of $251.76 to a high of $258.50. Yesterday, the shares fell 2.1%, which took the trading range below the 3-day low of $258.83 on volume of 2.2 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
SmarTrend Watching for Potential Rebound in Shares of iShares Nasdaq Biotechnology Index After 2.14% Loss
Comtex SmarTrend(R) - Tue Jul 08, 4:31PM CDT
iShares Nasdaq Biotechnology Index (AMEX:IBB) traded in a range yesterday that spanned from a low of $251.76 to a high of $258.50. Yesterday, the shares fell 2.1%, which took the trading range below the 3-day low of $258.83 on volume of 2.2 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
Today's 3 Most Volatile Biotech Stocks
Todd Campbell, The Motley Fool - Motley Fool - Tue Jul 08, 4:05PM CDT
Biotechnology stocks are never short on volatility and today was no different as markets turned lower and biotech stocks were particularly hard hit. The Nasdaq Biotechnology Index ETF dropped more than 2% as investors embraced safety and avoided...
